CRUK and Guardant Health collaborate on precision cancer drugs
Drug Discovery World
DECEMBER 5, 2023
Cancer Research UK (CRUK), Cancer Research Horizons, and precision oncology company Guardant Health have launched a collaboration to advance cancer treatment. The agreement will enable the parties to discuss opportunities for collaboration to support the charity’s research and clinical development activities, focusing primarily on its clinical trials run by its Centre for Drug Development.
Let's personalize your content